Milestone Pharmaceuticals Inc. Common Shares MIST
$1.05
+2.43%
at last close
Market Cap$131.35 million
P/E Ratio—
Div Yield—
Volume1.92M
52-Week Range
$1.00$3.06
Analyst Ratings
- Consensus
- Buy — 4 Buy · 0 Hold · 0 Sell (4 analysts)
- Avg. Price Target
- $6.50 (+516.1% upside)
Key Stats
- Today's Range
- $1.03 – $1.07
- 50-Day Range
- $1.01 – $1.42
- 52-Week Range
- $1.00 – $3.06
- Volume
- 1.92 million shs
- Average Volume
- 1.49 million shs
- Market Cap
- $131.35 million
- P/E Ratio
- —
- Dividend Yield
- —
Valuation
- P/E Ratio
- —
- Price / Book
- 7.21
- Price / Sales
- —
Short Interest
- Short Interest
- 0.01%
- Days to Cover
- 1.00
About Milestone Pharmaceuticals Inc. Common Shares
Milestone Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of cardiovascular medicines. Its approved product CARDAMYST (etripamil) nasal spray is available in the United States and is the self-administered treatment for use by patients anywhere, anytime an attack of PSVT occurs. It operates in single segment.
Related Stocks
Compare head-to-head: MIST vs LLY·MIST vs JNJ·MIST vs ABBV·MIST vs ABT
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.